دورية أكاديمية

XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)

التفاصيل البيبلوغرافية
العنوان: XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)
المؤلفون: Ferris, R.L., Mehanna, H., Schoenfeld, J.D., Tahara, M., Yom, S.S., Haddad, R.I., König, A., Salmio, S., Bajars, M., Tourneau, C. Le
المصدر: In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e17-e18
قاعدة البيانات: ScienceDirect
الوصف
تدمد:03603016
DOI:10.1016/j.ijrobp.2024.01.042